Literature DB >> 30233314

Lack of the Actin Capping Protein, Eps8, Affects NMDA-Type Glutamate Receptor Function and Composition.

Raffaella Morini1, Silvia Ferrara2, Fabio Perrucci3, Stefania Zambetti2, Silvia Pelucchi4,5, Elena Marcello4, Fabrizio Gardoni4, Flavia Antonucci2, Michela Matteoli1,6, Elisabetta Menna1,6.   

Abstract

Actin-based remodeling underlines spine morphogenesis and plasticity and is crucially involved in the processes that constantly reshape the circuitry of the adult brain in response to external stimuli, leading to learning and memory formation and supporting cognitive functions. Hence spine morphology and synaptic strength are tightly linked and indeed abnormalities in spine number and morphology have been described in a number of neurological disorders such as autism spectrum disorders (ASDs), schizophrenia and intellectual disabilities. We have recently demonstrated that the actin regulating protein, Epidermal growth factor receptor pathway substrate 8 (Eps8), is essential for spine growth and long term potentiation. Indeed, mice lacking Eps8 display immature filopodia-like spines, which are unable to undergo potentiation, and are impaired in cognitive functions. Furthermore, reduced levels of Eps8 have been found in the brain of a cohort of patients affected by ASD compared to controls. Here we investigated whether the lack of Eps8, which is also part of the N-methyl-d-aspartate (NMDA) receptor complex, affects the functional maturation of the postsynaptic compartment. Our results demonstrate that Eps8 knock out mice (Eps8 KO) neurons display altered synaptic expression and subunit composition of NMDA receptors (i.e., increased GluN2B-, decreased GluN2A-containing receptors) and impaired GluN2B to GluN2A subunit shift. Indeed Eps8 KO neurons display increased content of GluN2B containing NMDA receptors both at the synaptic and extrasynaptic level. Furthermore, Eps8 KO neurons display an increased content of extra-synaptic GluN2B-containing receptors, suggesting that also the synaptic targeting of NMDA receptors is affected by the lack of Eps8. These data demonstrate that, besides regulation of spine morphogenesis, Eps8 also regulates the synaptic balance of NMDA receptors subunits GluN2A and GluN2B.

Entities:  

Keywords:  EPS8; GluN2A; GluN2B; NMDA receptor; actin cytoskeleton; synapse

Year:  2018        PMID: 30233314      PMCID: PMC6133960          DOI: 10.3389/fnmol.2018.00313

Source DB:  PubMed          Journal:  Front Mol Neurosci        ISSN: 1662-5099            Impact factor:   5.639


  76 in total

Review 1.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

2.  Tonic NMDA receptor-mediated current in prefrontal cortical pyramidal cells and fast-spiking interneurons.

Authors:  Nadezhda V Povysheva; Jon W Johnson
Journal:  J Neurophysiol       Date:  2012-01-11       Impact factor: 2.714

3.  Temporal regulation of the expression locus of homeostatic plasticity.

Authors:  Corette J Wierenga; Michael F Walsh; Gina G Turrigiano
Journal:  J Neurophysiol       Date:  2006-06-07       Impact factor: 2.714

4.  Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.

Authors:  Francesco Bedogni; Clementina Cobolli Gigli; Davide Pozzi; Riccardo Lorenzo Rossi; Linda Scaramuzza; Grazisa Rossetti; Massimiliano Pagani; Charlotte Kilstrup-Nielsen; Michela Matteoli; Nicoletta Landsberger
Journal:  Cereb Cortex       Date:  2015-05-15       Impact factor: 5.357

5.  Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

Authors:  A W Dunah; Y Wang; R P Yasuda; K Kameyama; R L Huganir; B B Wolfe; D G Standaert
Journal:  Mol Pharmacol       Date:  2000-02       Impact factor: 4.436

6.  Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

Authors:  A W Dunah; D G Standaert
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

7.  EPS8 and E3B1 transduce signals from Ras to Rac.

Authors:  G Scita; J Nordstrom; R Carbone; P Tenca; G Giardina; S Gutkind; M Bjarnegård; C Betsholtz; P P Di Fiore
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

Review 8.  New waves in dendritic spine actin cytoskeleton: From branches and bundles to rings, from actin binding proteins to post-translational modifications.

Authors:  Enni Bertling; Pirta Hotulainen
Journal:  Mol Cell Neurosci       Date:  2017-05-04       Impact factor: 4.314

9.  Calcium-induced actin depolymerization reduces NMDA channel activity.

Authors:  C Rosenmund; G L Westbrook
Journal:  Neuron       Date:  1993-05       Impact factor: 17.173

10.  Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.

Authors:  J Tarabeux; O Kebir; J Gauthier; F F Hamdan; L Xiong; A Piton; D Spiegelman; É Henrion; B Millet; F Fathalli; R Joober; J L Rapoport; L E DeLisi; É Fombonne; L Mottron; N Forget-Dubois; M Boivin; J L Michaud; P Drapeau; R G Lafrenière; G A Rouleau; M-O Krebs
Journal:  Transl Psychiatry       Date:  2011-11-15       Impact factor: 6.222

View more
  3 in total

1.  Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmission.

Authors:  Miloslav Korinek; Inmaculada M Gonzalez-Gonzalez; Tereza Smejkalova; Dragana Hajdukovic; Kristyna Skrenkova; Jan Krusek; Martin Horak; Ladislav Vyklicky
Journal:  Sci Rep       Date:  2020-07-28       Impact factor: 4.379

Review 2.  Targeted NMDA Receptor Interventions for Autism: Developmentally Determined Expression of GluN2B and GluN2A-Containing Receptors and Balanced Allosteric Modulatory Approaches.

Authors:  Stephen I Deutsch; Zachary N M Luyo; Jessica A Burket
Journal:  Biomolecules       Date:  2022-01-22

Review 3.  Growth factor and receptor malfunctions associated with human genetic deafness.

Authors:  Sadaf Naz; Thomas B Friedman
Journal:  Clin Genet       Date:  2019-10-23       Impact factor: 4.296

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.